These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 6366805

  • 1. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F, Belogi M, Ansuini R, Campolucci G.
    Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF, Alvino-Demartino A, Mappa R, Donati C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [Abstract] [Full Text] [Related]

  • 4. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G, Pasotti C, Capra A.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [Abstract] [Full Text] [Related]

  • 5. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J, Amiguet JA, Carasusan J, Cebollada J, Carretero J.
    J Cardiovasc Pharmacol; 1990 Jan; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [Abstract] [Full Text] [Related]

  • 6. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
    Bagatin J, Sardelić S, Pivac N, Polić S, Ljutic D, Rakic D, Naranca M, Bojić L, Kovacić Z, Rumboldt Z.
    Int J Clin Pharmacol Res; 1998 Jan; 18(2):73-8. PubMed ID: 9675624
    [Abstract] [Full Text] [Related]

  • 7. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML, Soro S, Ferrara LA.
    Drugs Exp Clin Res; 1989 Jan; 15(11-12):587-90. PubMed ID: 2700322
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M, Agabiti-Rosei E, Carotti A, Innocenti P, Montervino C, Solinas E, Toso M, Muiesan G.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(8):332-7. PubMed ID: 7409934
    [Abstract] [Full Text] [Related]

  • 9. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Jan; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 10. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 11. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 12. [Clinical trial of the activity and therapeutic effectiveness of 3 drugs with diuretic and antihypertensive action].
    Tiberi F, Corinaldesi G.
    Minerva Med; 1981 Jan 21; 72(2):95-100. PubMed ID: 7007928
    [Abstract] [Full Text] [Related]

  • 13. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Fariello R, Innocenti P, Toso M, Valori C, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun 21; 19(6):249-55. PubMed ID: 7309298
    [Abstract] [Full Text] [Related]

  • 14. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 21; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 15. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Mar 21; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 16. Single-blind comparison of penbutolol and long-acting propranolol in general practice.
    Hayes G.
    Pharmatherapeutica; 1983 Mar 21; 3(7):456-63. PubMed ID: 6366804
    [Abstract] [Full Text] [Related]

  • 17. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV, Garrett BN, Kaplan NM.
    Arch Intern Med; 1981 Jul 21; 141(8):1015-9. PubMed ID: 7247587
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
    Nissinen A, Tuomilehto J.
    Pharmatherapeutica; 1980 Jul 21; 2(7):462-8. PubMed ID: 7010382
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
    Widimský J, Lánská V, Hulínský V, Balazovjech I, Havlík V, Havránek P, Kroupa E, Nikodýmová L, Pátek F, Svítil F, Svihovcová P.
    Vnitr Lek; 1996 Apr 21; 42(4):223-8. PubMed ID: 8693706
    [Abstract] [Full Text] [Related]

  • 20. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN.
    Int J Clin Pharmacol Res; 1983 Apr 21; 3(3):153-6. PubMed ID: 6679518
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.